Attachments
11-13-2026.xlsx
by Pankti Antani
Nov 12, 2026 4:33 PM ET
The US high yield primary market remained quiet coming back from the Veterans Day holiday with no new deals announced or priced today.
However, the European market maintained its active pace with two deals from the calendar priced today.
Priced today in the European market were Amplifon S.p.A. EUR600m 5yNCL sr notes, priced 4.875% at 100 (vs final yield of 4.875%, final guidance of 4.875%-5% WPIR, price talk of 5%-5.25%, and IPT of 5.25%-5.5%); and Odido Holding BV EUR900m (up from EUR600m) sr sec notes two-part, consisting of EUR500m (up from min. EUR250m) 6yNC2 fixed rate notes, priced 6.50% at 100 (vs final yield of 6.50%, revised price talk of 6.5%-6.75%, price talk of 6.75%-7%, and IPT of 7.00%-7.25%) and EUR400m (up from min. EUR250m) 6yNC1 FRN, priced 3mE+325bps at 100 (vs final terms of E+325 at par, revised price talk of E+325-350 at par, price talk of E+350-375 at par, and IPT of E+375bp at 99.50-par).
The US high yield new issue deal flow for the week remains three deals (three tranches) for $2.275bn. That is only in the bottom range of this week’s syndicate desk estimates of $2bn to $6bn (most were around the $3bn-$5bn range). Our guess was $5bn.
At $11.94bn, the November month-to-date volume is quickly approaching the low-end of this month’s syndicate desk estimates of $15bn to $30bn (most were around $18bn-$25bn). Our guess was $22bn.
| November | November | November | Weekly | Weekly | Weekly |
| Volume | Deal Count | Tranche Count | Volume | Deal Count | Tranche Count |
2026 to date | $11,940 | 12 | 13 | $2,275 | 3 | 3 |
2025 to date | $12,885 | 14 | 16 | $3,950 | 4 | 5 |
$ Difference | -$945 | -2 | -3 | -$1,675 | -1 | -2 |
% Difference | -7% | -14% | -19% | -42% | -25% | -40% |
2025 final | $24,938 | 26 | 29 | $8,100 | 8 | 9 |
$ Difference | -$12,998 | -14 | -16 | -$5,825 | -5 | -6 |
% Difference | -52% | -54% | -55% | -72% | -63% | -67% |
| Year | Year | Year | Fourth Quarter | Fourth Quarter | Fourth Quarter |
| Volume | Deal Count | Tranche Count | Volume | Deal Count | Tranche Count |
2026 to date | $285,112 | 282 | 317 | $26,545 | 30 | 32 |
2025 to date | $288,105 | 321 | 358 | $30,703 | 32 | 36 |
$ Difference | -$2,993 | -39 | -41 | -$4,158 | -2 | -4 |
% Difference | -1% | -12% | -11% | -14% | -6% | -11% |
2025 final | $322,748 | 358 | 399 | $65,346 | 69 | 77 |
$ Difference | -$37,636 | -76 | -82 | -$38,801 | -39 | -45 |
% Difference | -12% | -21% | -21% | -59% | -57% | -58% |
| Top Ten November US$ High Yield Volume | November US$ HY Volume Since the end of the Credit Crisis | US High Yield Monthly Volume | All Months US High Yield Top Ten Table | |||||
Rank | Year | Amount | Year | Amount | Date | Volume | Date | Volume |
|
1 | Nov-2019 | $37,434 | Nov-2026 | $11,940 | Nov-2026 | $11,940 | Mar-21 | $61,315 | 1 |
2 | Nov-2020 | $31,615 | Nov-2025 | $24,938 | Oct-2026 | $14,605 | Jun-20 | $60,730 | 2 |
3 | Nov-2021 | $31,400 | Nov-2024 | $9,150 | Sep-2026 | $51,256 | Sep-25 | $57,550 | 3 |
4 | Nov-2010 | $31,293 | Nov-2023 | $19,375 | Aug-2026 | $12,075 | Aug-20 | $52,925 | 4 |
5 | Nov-2012 | $29,443 | Nov-2022 | $9,165 | Jul-2026 | $18,032 | Jan-21 | $51,905 | 5 |
6 | Nov-2006 | $28,844 | Nov-2021 | $31,400 | Jun-2026 | $34,390 | Sep-26 | $51,256 | 6 |
7 | Nov-2014 | $26,745 | Nov-2020 | $31,615 | May-2026 | $27,210 | Apr-21 | $49,200 | 7 |
8 | Nov-2025 | $24,938 | Nov-2019 | $37,434 | Apr-2026 | $37,709 | Sep-20 | $47,515 | 8 |
9 | Nov-2017 | $24,808 | Nov-2018 | $4,020 | Mar-2026 | $21,040 | May-21 | $47,350 | 9 |
10 | Nov-2015 | $23,438 | Nov-2017 | $24,808 | Feb-2026 | $28,685 | May-20 | $47,347 | 10 |
|
|
| Nov-2016 | $15,471 | Jan-2026 | $28,170 |
|
|
|
|
|
| Nov-2015 | $23,030 | Dec-2025 | $22,590 |
|
|
|
|
|
| Nov-2014 | $26,745 | Nov-2025 | $24,938 |
|
|
|
|
|
| Nov-2013 | $20,378 | Oct-2025 | $17,818 |
|
|
|
|
|
| Nov-2012 | $29,443 |
|
|
|
|
|
|
|
| Nov-2011 | $21,970 |
|
|
|
|
|
|
|
| Nov-2010 | $31,293 |
|
|
|
|
|
|
|
| Average 2010-2025 | $22,515 |
|
|
|
|
|
The US high yield secondary market was weaker following stocks and treasuries today. UST yields gapped higher (10y UST yield +13bps to 5.13%), while stocks inched lower (DJIA -189; S&P -27; NASDAQ -100). The US high yield cash market was down an 1/8 - 1/4 point.
The CDX HY46 was up over 1/16 of a point to 106.245.
This week’s new issues performed well in the secondary market today. Nielsen and Phoenix Aviation were both up a 1/4 point since Tuesday’s close, while Peloton was up an 1/8.
The secondary performance of this week's HY new issues | |||||||||
Issue Date | Issuer | Type | Maturity | Coupon | Price | Bid | Ask | Change | 1-Day Change |
11/10/26 | Neptune BidCo US Inc (Nielsen) | sr sec notes | 12/01/33 | 10.500% | 100.000 | 101.125 | 101.500 | 1.125 | 0.250 |
11/10/26 | Phoenix Aviation Capital Limited | sr notes | 07/15/30 | 9.250% | 100.500 | 100.875 | 101.375 | 0.375 | 0.250 |
11/10/26 | Peloton Interactive Inc | sr sec notes | 02/15/32 | 8.625% | 100.000 | 101.750 | 102.000 | 1.750 | 0.125 |
High yield new issues priced today:
11/12/2026 Odido Holding B.V. (TMOBNL) EUR900m (up from EUR600m) 144A/Reg S sr sec notes 2-part. B1/B/BB-. Via NatWest (B&D)/Goldman Sachs Bank Europe SE jt glocos and jt physical books, ABN AMRO/Barclays/Coöperatieve Rabobank/ING/JPM/Morgan Stanley/SMBC passive jt books. No reg rights. List TISE. NY law. Settles 11/17 (T+3).
EUR500m (up from min. EUR250m) due 12/31/32 (6y). NC2 (11/17/28) (MWC B+50bp), then at 103.250 11/17/28, 101.625 11/17/29, 100.000 11/17/30. Equity claw: 2y 40% at 106.50. Special call: 10% per year the first 2 years at 103. CoC at 101. Pays June 30 and Dec 31, starting 06/30/27. Denoms: 100kx1k. Reg S ISIN: XS3571992711; 144A ISIN: XS3571992984. IPT: 7%-7.25%. Price talk: 6.75%-7%. Revised price talk: 6.5%-6.75%. Final terms: 6.5%. Priced: 6.5% at 100. +329bp vs 2.5% DBR 11/15/32.
EUR400m (up from min. EUR250m) due 12/31/32 (6y). NC1 (11/17/27) (MWC B+50bp), then at 100.000 11/17/27. CoC at 101. Pays March 31, June 30, September 30 and Dec 31, starting 03/31/27. Denoms: 100kx1k. Reg S ISIN: XS3570745334; 144A ISIN: XS3570745680. IPT: E+375 / 99.50-par. Price talk: E+350-375 / par. Revised price talk: E+325-350 / par. Final terms: E+325 / par. Priced: 3mE+325bps at 100.
Did investor call at 12:00 UKT / 13:00 CET 11/10 (also did fixed income investor meetings 11/10-11/11). Books closed at 14:15 UKT / 15:15 CET 11/12. Reconfirms were due by 15:30 UKT / 16:30 CET 11/12. FTT 07:30 UKT 11/13. ToE 16:44 UKT 11/12. UOP: Together with a EUR1.798bn equity contribution from Apax and EUR425m cash on balance sheet, to acquire Warburg Pincus 50% stake in Odido (EUR1.912bn equity value and EUR809m distributions to Warburg Pincus), to partially repay 2029 Term Loan B, to pay transaction fees and expenses, and for GCP. Equity sponsor: Apax. Biz: Largest B2C mobile postpaid operator in the highly attractive and growing Dutch Telco market. HQ: The Hague, Netherlands.
NetRoadshow registration link: https://www.netroadshow.com/events/login/1PeTHmojALJTMJX70boVKor51fmn2qMKWwJqY. Dial-in UK: +44 20 3936 2999; Access Code: 627470.
11/12/2026 Amplifon S.p.A. (AMPIM) EUR600m Reg S, bearer, NGN sr notes due 11/19/31 (5y). MWC (OBL+30bp)/M&A call at 100% (proceeds held in escrow until closing)/3m par call. BB+ (stable) by S&P. Via GS (B&D)/JPM jt glocos and jt lead managers/BNP/DB/HSBC/ING/Mediobanca jt active books, Banca Akros/CaixaBank/CA/UniCredit other bookrunners. List Luxembourg Stock Exchange (Euro MTF). English law. CoC at 100. Pays annually. Denoms: 100kx1k. Settles 11/19 (T+5). Reg S ISIN: XS3535786936. IPT: 5.25%-5.5%. Price talk: 5%-5.25%. Final guidance: 4.875%-5% WPIR.
Priced: 4.875% at 100.00. +169.2bp vs 2.9% OBL 10/08/31.
Did a series of virtual fixed income investor calls 11/10-11/11. Books closed at 1:00pm UKT / 2:00pm CET 11/12. Reconfirms were due by 2:00pm UKT / 3:00pm CET 11/12. Pricing 11/12 (today's business). FTT 08:00 UKT. ToE 16:41 UKT. UOP: along with a EUR900m term loan and EUR640m cash on hand and/or a draw on its revolver, to finance the cash consideration of the GN Hearing Carve-Out Acquisition from GN Store Nord A/S (EUR1.69bn in cash and 56m Amplifon shares), to redeem its existing EUR350m 1.125% senior notes due February 18, 2027 (callable November 13, 2026 at 100), and transaction costs, fees and expenses (acquisition announced March 15, 2026). Biz: Amplifon is a global leader in hearing healthcare. HQ: Milan, Italy.
DealRoadshow direct link: https://dealroadshow.finsight.com/e/AMPLIFON26GIC. Entry code: AMPLIFONGIC26.
CFR High Yield Forward Calendar
===================== [ 11/09/2026 Week ] ===============
APi Group (APG) has mandated J.P. Morgan and Barclays to arrange a series of virtual fixed income investor calls starting November 11, 2026. Subject to market conditions, a benchmark sized EUR senior unsecured notes offering (5y) may follow. Issue ratings B1/B+/BB+.
Pre-recorded Global Investor Call available immediately, or with live Q&A Thursday 11/12 (3pm UKT / 10am ET) (also did fixed income investor meetings 11/11-11/13, London and Paris). Biz: A market leader in fire and life safety, security, elevator and escalator, and specialty services. HQ: New Brighton, MN, USA.
NetRoadshow registration link (GIC with live Q&A, 3pm UKT/10am ET 11/12): https://www.netroadshow.com/events/login/1PeTHmojCnCl4PubUTAMLetIGMU6bxgSie3Cy. Presentation link (with recording): www.netroadshow.com/nrs/home/#!/?show=67538da5; Access Code: api26.
====================== [ November 2026 ] ===============
Mozart Merger Sub (DE) Inc (CCC Intelligent Solutions Holdings Inc) (CCC) total $2.85bn financing split between sr sec term loan B and sr sec notes. --/B-/BB (--/stable/stable). Nov biz for the notes (lender call 11/09, loan commitments due 5pm 11/17 via JPM/Citi/Jefferies/RBC/UBS/CapOne). UOP: fund the LBO of CCC by GTCR and Elliot Investment Management LLP for $7.75 per share in cash ($4.6bn equity value $6.1bn enterprise value). The deal will be funded with cash equity, pfd equity and new debt. JPM/Citi have committed to provide the debt financing. Closing is expected in Q1 2027. Biz: a leading SaaS and AI platform powering the multi-trillion-dollar insurance and repair economy. HQ: Chicago, IL. (Acquisition announced 10/15/2026).
CVR Energy Inc (CVI) $1bn sr sec notes. B2/--/BB- (positive/--/positive). Nov biz (loan commitments due at 12pm 11/19). UOP: Along with a $1.5bn sr sec term loan B via Barc/WFS/Mizuho, to fund the acquisition of two refineries (St Paul Park, MN and Mandan, ND) and the related marketing business from Marathon Petroleum Corp (MPC) and others for $4.2bn in cash. CVR also priced $500m common stock (10,515,248 shares at $47.55 via Barc/Jeff) on 11/03/26. Barc/WFS/Mizuho committed to provide $2.5bn bridge loan to backstop the permanent secured debt financing. The rest of the financing consists of an $800m cvt pfd equity investment from Trafigura US Holdings Inc, a $250m draw on its ABL revolver, and $500m of cash on hand. In connection with the new secured financing, CVR’s existing 7.500% Senior Notes due 2031 and 7.875% Senior Notes due 2034 will become secured on an equal and ratable basis with the new secured debt, and CVR’s existing $183m 5.750% Senior Notes due 2028 will be redeemed. Closing is expected by the end of 2026. Equity sponsor: Icahn Enterprises. Biz: a diversified holding company primarily engaged in renewables, petroleum refining and marketing, and nitrogen fertilizer manufacturing. HQ: Sugar Land, TX. (Acquisition announced 11/03/2026).
====================== [ 2026 / 2027 ] ===============
The Brink's Co (BCO) $2.124bn sr notes. Via MS. (Existing sr unsec notes were affirmed at Ba3/BB/BB+ (stable/stable/stable)). UOP: along with cash on hand, to fund the acquisition of NCR Atleos Corp (NATL) for $6.6bn implied value, consisting of $2.2m in cash ($30.00 per share in cash) and 13.3m BCO cmn shares (0.1574 cmn share of BCO per NATL share) ($50.40 per share total implied value), and the assumption of $2.6bn NATL debt. MS has provided a $2.124n bridge loan to fund the cash portion and refinance NATL's debt (BCO will also use cash on hand) (The bridge loan originally was $4.5bn total size consisting of $2.276bn sr unsec bridge loan to fund the cash portion of the acquisition, $873m sr sec bridge loan backstopping the amend and extend of NCR Atleos term loan A with BofA, and $1.35bn sr sec bridge loan backstopping the $1.35bn 9.50% sr sec notes due 2029, in case Brink's and NCR Atleos do not receive the requisite consents from the noteholders to keep the bond outstanding). Closing is expected in Q1 2027. Biz: provider of cash management, secure logistics and security services. HQ: Richmond, VA. (Acquisition announced 02/26/2026).
++++10/08/2026: Brinks received the UK's Competition and Markets Authority (CMA) acceptance in principle of the proposed remedy relating to the pending acquisition of NCR Atleos. Brinks will divest NoteMachine/TestLink UK.
++++09/11/2026 update: The UK Competition and Markets Authority initiated its first-phase inquiry into the acquisition.
++++07/22/26 update: India clears the acquisition of NCR Atleos.
++++06/30/26 update: BCO and NATL shareholders approve the merger.
++++05/12/26 update: the FTC granted early termination of the HSR waiting period.
+++04/07/26 update: on 03/31/36 Brink's increased its existing $2.225bn term loan A with a new $1.025bn delayed-draw term loan via BofA and increased its revolver by $600m. This financing will replace a portion of the bridge loan.
+++03/11/26 update: NCR Atleos announced they had received the requisite consents and amended the CoC definition on its 9.50% sr sec notes due 2029.
+++03/05/26 update: NCR Atleos Corp commenced a consent solicitation with respect to its $1.35bn 9.50% sr sec notes due 2029. The Proposed Amendments seek to amend the defined term “Change of Control” to provide that the Mergers will not constitute a Change of Control and to add or amend certain other defined terms contained in the Indenture related to the foregoing.
The amended and restated credit agreement increases the size of the existing credit facility from $2.225 billion to $3.85 billion. The increase is structured as a $1.025 billion delayed draw term loan and a $600 million increased revolving credit commitment, and the proceeds are intended to be used to fund part of the cash consideration for Brink’s potential acquisition of NCR Atleos Corporation (“NCR Atleos”), refinance indebtedness of NCR Atleos, and fund general corporate purposes. The amended and restated credit agreement will mature on March 31, 2031. Pricing is expected to remain at Term SOFR + 150 basis points through the consummation of Brink’s proposed acquisition of NCR Atleos, subject to Brink’s consolidated net leverage ratio in accordance with the terms of the amended and restated credit agreement. The acquisition remains subject to customary closing conditions, including regulatory approval and shareholder approvals from both companies.
Fertitta Gaming/Caesars Entertainment Inc (FRTITA) $1.675bn sr sec notes. UOP: along with $500m sr sec incremental term loan A-1, $1.675bn sr sec incremental term loan B-2, and $750m 1y sr sec bridge loan (also $2bn revolver), to fund the acquisition of Caesars Entertainment Inc (CZR) by Fertitta Entertainment Inc for $31.00 per share in cash representing an equity value of $5.7bn or an enterprise value of $17.6bn including the assumption of approx $11.9bn net debt. Fertitta plans on funding the transaction with $2.7bn equity financing provided by Fertitta Entertainment and committed debt financing obtained from 10 banks. MS/GS are financial advisors to Fertitta. The new entity will be a wholly owned sub of Fertitta Gaming Holdco LLC. Biz: gaming, entertainment, and restaurants. HQ: Houston, TX. (Acquisition announced 05/28/2026).
++++09/14/26 update: the FTC makes a second request for information.
++++09/23/26 update: CZR shareholders approve the merger.
Solstice Advanced Materials Inc (SOL, SOLADV) $ TBD notes. (existing sr unsec Ba2/BB+/ BB+ (stable/Watch negative/Watch negative)). Via GS. UOP: along with cash on hand, to fund the acquisition of Element Solutions Inc (ESI) for $50.10 per share in a cash and stock transaction for a total valuation of $14.5bn including the assumption of net debt. Element shareholders will own around 44% of the combined company. The transaction consists of $10.00 per share in cash and 0.500 in Solstice shares per ESI share. Solstice obtained a $4.7bn bridge facility via GS to help fund the cash portion of the transaction. Closing is expected in H1 2027. Biz: is a global, differentiated advanced materials company and a leading global provider of refrigerants, semiconductor materials, protective fibers and healthcare packaging. HQ: Morris Plains, NJ. (Acquisition announced 07/06/2026).
Nuvei Corp US$750m sr sec notes. UOP: along with $1.5bn sr sec term loan, to fund the acquisition of Payoneer (PAYO) for US$7.40 per share in cash or a total equity value of approx $2.75bn. BMO/RBC/Barc/UBS/WFS are providing $2.7bn committed financing for the transaction (including $200m cash flow bridge loan and $250m incremental revolver). Closing is expected mid 2027. Biz: develops electronic payment infrastructure. HQ: Montreal, QC. (Acquisition announced 06/15/26).
Dana Inc (DAN) $ TBD notes. UOP: fund the Reverse Morris Trust merger with Eaton's mobility business with an enterprise value of $5.1bn (the combined company will have an enterprise value of over $10bn). Dana will pay a $1.1bn distribution to Eaton. Eaton shareholders will own at least 50.1% and Dana shareholders will own approximately 49.9% of the combined company at closing. GS has committed to provide a $2.6bn bridge loan backstop the $1.1bn distribution and repay certain existing Dana debt. The permanent financing is expected to include term loans and sr notes. Closing is expected around the end of Q1 2027 (only one regulatory approval is pending). Shareholder meeting scheduled for 12/0726. (Acquisition announced 06/11/26).
Veris Residential Inc (VRE) $2.08bn notes. UOP: repay the $2.08bn bridge loan incurred to fund the acquisition of Veris for $19.00 per share in cash ($3.4bn enterprise value) by Affinius Capital and Vista Hill Partners, which contributed $1.07bn in cash equity. GS/UBS provided the $2.08bn bridge loan. Biz: a REIT that primarily owns, operates, acquires and develops premier Class A multifamily properties in the Northeast US. HQ: Jersey City, NJ. (Acquisition announced 02/23/26. Closed 05/27/26).
Hapag-Lloyd AG (HPLGR) up to US$2.5bn notes. Existing sr unsec Ba1/BB+. UOP: along with cash on hand, to fund the acquisition of ZIM Integrated Shipping Services Ltd for US$35.00 per share in cash or approx US$4.2bn total consideration. Closing is expected by the end of 2026. Biz: leading liner shipping company. HQ: Hamburg, Germany. (Acquisition announced 02/16/26).
++++08/10/26 update: the Israeli government meeting to review the sale of ZIM has been postponed to 09/09/26 with the majority currently expected to oppose the sale.
++++09/30/2026 update: ZIM integrated says Hapag-Lloyd informed ZIM that it intends to submit a revised proposal and seek approval from the GCA and the State of Israel for the takeover of ZIM.
Option Care Health Inc (OPCH) $ sr sec and sr unsec notes. UOP: along with sr sec term loan B, to fund the acquisition of Option Care Health (B2/B) by McKesson Corp (MCK) (A3/BBB+/A-) and CD&R for $32.05 per share in cash representing an enterprise value of $5.8bn. Option Care Health will remain a separate company, led by its own management. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The transaction also establishes a framework for McKesson’s future acquisition of CD&R’s interest in Option Care Health, subject to specified conditions and regulatory approvals. Following the closing of the transaction, McKesson intends to account for its minority interest in Option Care Health using the equity method of accounting, recording its share of Option Care Health’s net income or loss in Other Income, net. The parties have obtained an equity commitment letter of $2.873bn ($1.4bn from McKesson and $1.475 from CD&R) and a debt commitment letter of up to $3.15bn from BofA/Barc/GS/Jefferies/WFS, as well as up to $500m in revolving commitments to help fund the purchase price. Closing is expected in H1 2026. Biz: is the nation’s largest independent provider of home and alternate site infusion services. HQ: Bannockburn, IL (Acquisition announced 10/06/2026).
Penske Automotive Group Inc (PAG) up to $1.8bn sr sub notes. Via JPM/BofA/WFS jt books. UOP: take private the remaining shares that PAG and Mitsui & Co Ltd does not currently own. Motown Acquisition Corp, a group consisting of Penske Corp and Mitsui & Co Ltd will acquire the public shares outstanding at $212.00 per share in cash representing an enterprise value of $16.3bn. Pre announcement, Penske Corp already owned ~52% and Mitsui owned ~20% of PAG. At closing, Penske will own ~64% and Mitsui will own ~36%. JPM/BofA/WFS have provided a 1y sr unsec bridge loan for $1.8bn to backstop the debt financing. This bridge loan will be reduced by up to $1.8bn of additional sr sub notes and/or up to $1.1bn additional term loans. Penske Corp and Mitsui will provide up to $2.2bn in cash equity. Closing is expected in Q1 2027. Biz: an international transportation services company that operates automotive and commercial truck dealerships principally in the US, the UK, Canada, and Western Europe, and distributes commercial vehicles, diesel engines, gas engines, power systems and related parts and services principally in Australia and New Zealand. HQ: Bloomfield Hills, MI. (Acquisition announced 10/15/2026).
Silgan Metal Containers and Closures possible notes. UOP: $4.9bn of new debt will be raised to fund the acquisition of Trivium Packaging BV by Silgan Holding Inc (SLGN) and American Industrial Partners (AIP) from Ontario Teachers Pension Plan (58%) and Ardagh Packaging (42%) in a cash transaction that values Trivium at a $3.4bn enterprise value ($3.2bn cash purchase price). Silgan will combine its metal Containers segment and Food and Beverage Flat Cap Closures businesses ($3.8bn enterprise value) with Trivium, a global supplier of infinitely-recyclable metal packaging for the world’s leading brands. Silgan will receive $2.3bn in cash, which it will use to repay debt. Silgan will also rollover $1.5bn in equity. Silgan will own a 60% controlling interest in Silgan MCC and AIP will own the other 40% and contribute $1bn in cash equity to support the acquisition and fund future growth. Silgan has obtained fully-committed debt financing from a consortium of banks (WFS/GS/RBC/DB/BofA) to backstop the debt financing. Closing is expected in mid 2027. Biz: Silgan Holdings is a supplier of metal packaging in the form of cans and aerosol containers, serving a broad range of end-use categories, including food, seafood, pet food and nutrition, as well as beauty and personal care. HQ: Norwalk, CT. (The acquisition was announced 10/19/2026).
QIAGEN NV (QGEN) EUR/US$ notes. 2027 biz. UOP: total debt financing of around $5bn will be used to fund the LBO of QIAGEN by a consortium lead by EQT along with Luxiva SA (a sub of Abu Dhabi Investment Authority (ADIA)), and OPP Investment Board Europe Inc for EUR46.50 per share in cash or an enterprise value of EUR10.8bn (approx $12.1bn), including EUR1.1bn of net debt. MS/Jeff/DB/SMBC/CA/UniCredit have committed to provide around EUR5bn of debt financing for the deal. Closing is expected by mid 2027. Biz: a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. HQ: Venlo, Netherlands. (Acquisition announced 10/22/2026).